Prevention of Rh Sensitisation WHO Technical Report Series 1971 No 468.
2.
Haemolytic Disease of the Newborn.Report of the Standing Medical Advisory Committee for the Central Health Services. 1976.
3.
ibid, Committee Department of Health and Social Security. Addendum 1981.
4.
Recommendations for the use of Anti-D Immunoglobulin. Prescribers' Journal1991; 31: 137–145.
5.
WoodrowJC. Rh Immunisation and its Prevention. Series Haematologica, Vol III1970.
6.
ClarkeCAMcConnellRB. Prevention of Rh Haemolytic Disease. Charles C Thomas PublisherSpringfield, Illinois1972.
7.
MollisonP LControlled Trial of Various Anti-D Dosages in Suppression of Rh Sensitisation following pregnancy. MRC Working Party. Br Med J, 1974; 2: 75–80.
8.
RobertsHMitchellR.The Use of Anti-D Prophylaxis in the Management of Miscarriage in General Practice. Health Bulletin1991; 49/4: 245–249.
9.
Practical Aspects of Anti-D Prophylaxis of Haemolytic Disease of the Newborn. Association of Clinical Pathologists Broadsheet No 90, December 1978.
10.
UrbaniakSJ. Rh(D) Haemolytic Disease of the Newborn: The Changing Scene. Br Med J1985; 291: 4–6.
11.
HughesRGCraigJIOMurphyWGGreeIACauses and Clinical Consequences of Rhesus (D) Haemolytic Disease of the Newborn — A Study of a Scottish Population 1985–1990. Br J Obst and Gynae. 1994; 101. 4:297–300.